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Executive Summary/Abstract 
BACKGROUND 
Youth drug use is a severe problem worldwide. Usage of cannabis, amphetamine 
ecstasy and cocaine, referred to here as non-opioid drugs, are strongly associated 
with a range of health and social problems.  
Functional Family Therapy (FFT) is a short-term, manual-based, behaviorally 
oriented family therapy program for young people with behavior problems such as 
drug abuse, juvenile delinquency and violence. Delivered in an outpatient setting, it 
aims to help young people and their families by improving family interactions and 
relationship functioning by addressing dysfunctional individual behavior.  
As with many other forms of family therapy, FFT targets young people and their 
families as a system. As such, it recognizes the important role of the family system in 
the development and treatment of young people’s drug abuse problems. 
OBJECTIVES 
The main aim of this review is to evaluate the current evidence on the effects of FFT 
on drug abuse reduction for young people in treatment for non-opioid drug use.  
SEARCH METHODS 
A wide range of electronic bibliographic databases were searched using a relatively 
narrow search strategy, in July 2013. We performed extensive searches in a broad 
selection of government and policy databanks, grey literature databases, citations in 
other reviews and included primary studies, and by hand searches of relevant 
journals and internet searches using Google. We also corresponded with researchers 
in the field of FFT. No language or date restrictions were applied to the searches.  
SELECTION CRITERIA 
To be eligible for inclusion, studies must have: 
 involved a manual-based outpatient FFT treatment for young people 
aged 11-21 years enrolled for non-opioid drug use; 
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 used experimental, quasi-experimental or non-randomized controlled 
designs; 
 reported at least one eligible outcome variable measuring abstinence, 
reduction of drug use, family functioning, education or vocational 
involvement, retention, risk behavior or other adverse effects;  
 not focused exclusively on treating mental disorders; and  
 had FFT as the primary intervention.  
DATA COLLECTION AND ANALYSIS 
The literature search yielded a total of 6,719 records, which were screened for 
eligibility based on title and abstract. From these, 108 potentially relevant records 
were retrieved and screened in full text, of which 9 records were potentially relevant. 
Finally, two studies based on three records were included in the review. Meta-
analysis was not possible because only one study provided numerical results on the 
effect of FFT on drug use reduction.  
RESULTS 
Two studies were included and both analyzed relative effects, comparing FFT to 
other interventions. Only one study provided numerical results on drug use 
reduction comparing FFT to two other interventions (CBT and a group 
intervention). The reported results indicate a positive effect favoring FFT on drug 
use frequency at 4-month follow up, with no statistically significant difference at 7-
month follow up. 
AUTHORS ’  CONCLUSIONS  
There is insufficient firm evidence to allow any conclusion to be drawn on the effect 
of FFT for young people in treatment for non-opioid drug use. There is a need for 
more research, and particularly for more methodologically rigorous studies in the 
field of treatment for young drug users.  
The aim of this systematic review was to explore what is known about the 
effectiveness of FFT for the purpose of reducing youth drug use. The evidence found 
does not provide a basis for drawing conclusions about actual outcomes and 
impacts. Consequently, no substantive conclusion on the effectiveness can be made, 
neither supporting nor rejecting of the present FFT treatment approach. 
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1 Background 
1.1  DESCRIPTION OF THE CONDITION 
Youth drug abuse1 of the kind that persists beyond the experimentation phase is a 
severe problem worldwide (United Nations Office on Drugs and Crime (UNODC), 
2010). Abuse of non-opioid drugs such as cannabis, amphetamine and cocaine is 
strongly associated with a broad range of negative health implications such as traffic 
accidents, sexually transmitted diseases, mental problems and suicide as well as 
social problems including poor academic achievement, delinquency and violent 
behavior (Deas & Thomas, 2001; Essau, 2006; Rowe & Liddle, 2006; Office of 
National Drug Control Policy (ONDCP), 2000; Shelton, Taylor, Bonner, & van den 
Bree, 2009; Nordstrom & Levin, 2007; Lynskey & Hall, 2000).  
While cannabis, amphetamine, cocaine and other non-opioid drugs remain illegal in 
most countries, surveys indicate widespread prevalence. In the US, 25.5 percent of 
12th-grade students report having used an illicit drug (any kind) within the last 
month (Johnston, O’Malley, Miech, Bachman, & Schulenberg, 2014). In Canada, 21 
percent of 15-24 year olds report having used of some kind of illicit drugs within the 
last year (Health Canada, 2011). In Australia, seven percent 12-17 year olds report 
using some kind of drug within the last month (White & Smith, 2009). The 
European Monitoring Centre for Drugs and Drug Addiction has found that that 
within Europe prevalence differs significantly from country to country but that 
overall around a quarter of Europeans report having used some kind of illicit drug in 
their lifetime (European Monitoring Centre for Drugs and Drug Addiction 
(EMCDDA), 2013). 
The prevalence of specific kinds of illicit drug abuse varies significantly, with 
cannabis generally being the most commonly used drug. In the US,  22.7 percent of 
12th-grade students report having used marijuana/hashish (types of cannabis), 4.1 
percent amphetamine, and 1.1 percent cocaine during the last 30 days before the 
National Survey on Drug Use conducted in 2013 (Johnston et al., 2014).  The 
European Drug Report of 2013 indicates that 11.7 percent of the 15 to 34 year-olds in 
                                                        
1 The terms ‘use’, ‘abuse’ and ‘dependence’ are often used interchangeably and refer to an addiction 
stage of non-medical drug usage. 
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Europe have used cannabis, 1.3 percent amphetamine, and 1.9 percent used cocaine 
during the last year (EMCDDA, 2013).  
Although not all young drug users progress to severe dependence, some do and may 
therefore require treatment (see e.g. Crowley, Macdonald, Whitmore & Mikulich, 
1998). Research draws attention to the significant gap between the number of young 
people classified as in need of treatment and the number of young people who 
actually receive such treatment (Substance Abuse and Mental Health Services 
Administration (SAMHSA), 2010; National Survey on Drug Use and Health 
(NSDUH), 2007). In the US, for example, 7.2 million people aged 12 or older are 
classified as needing treatment for illicit drug abuse, but only 1.4 million of these 
young people actually receive treatment at a specialty facility for an illicit drug abuse 
problem (SAMHSA, 2011).  
The treatment usually provided to young people is delivered in outpatient settings. 
Accordingly, 90 percent of the 89,521 clients under age 18 registered in substance 
abuse treatment in 2012 by SAMHSA were in outpatient treatment, which is the 
same proportion as the total treatment population (Substance Abuse and Mental 
Health Services Administration (SAMHSA), 2013). Equal proportions of the clients 
under age 18 were enrolled in facilities with a primary focus on substance abuse 
treatment and in facilities whose primary focus were provision of a mix of mental 
health and substance abuse treatment services; this differs from the total treatment 
population as youth tend to be treated in dual focus facilities more often than adults 
(SAMHSA, 2013). Cognitive-behavioral therapy and motivational interviewing are 
specific therapeutic approaches that are used at least sometimes by most treatment 
facilities (91% and 87% respectively: SAMHSA, 2013). 
There is growing public concern about the effectiveness and high cost of available 
treatments for young people, and the high rates of treatment dropout and post-
treatment relapse to drug abuse (Austin, Macgowan, & Wagner, 2005; Najavits & 
Weiss, 1994; Stanton & Shadish, 1997). While relapse must be acknowledged as an 
expected part of any treatment process targeting individual drug use, efforts should 
be made to make treatment as attractive, accessible and relevant as possible for 
young people in order to minimize the risk of unwarranted dropout and continuous 
relapse (Simmons et al., 2008; National Institute on Drug Abuse (NIDA), 2009). 
Furthermore, the services provided should be empirically supported to increase the 
likelihood that (a) treatment will be successful, and (b) public spending supports the 
interventions that are the most effective.  
Researchers point to the fact that many research projects have empirically validated 
different types of treatment approaches as effective for young drug users (e.g. Rowe 
& Liddle, 2006; Waldron, Turner, & Ozechowski, 2006; Williams, Chang, & 
Addiction Centre Adolescent Research Group, 2000; Austin et al., 2005). The 
effectiveness, however, depends upon the interplay between a specific intervention 
and individual factors such as gender, ethnicity, family composition, co-morbidity 
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and history of drug abuse (Brannigan, Schackman, Falco, & Millman, 2004; 
Hawkins 2009; Horsfall, Cleary, Hunt, & Walter 2009). For example, research 
suggests that treatment outcomes of a specific program such as Functional Family 
Therapy may vary for different ethnic groups (Hops et al, 2011; Flicker, Waldron, 
Turner, Brody, & Hops, 2011). The current challenge in the field of substance abuse 
treatment for young people is therefore to establish not only what works best but 
also what works for different subgroups.  
In terms of treatment types, there is some documentation of promising individually-
based cognitive and motivational therapies (Waldron & Turner, 2008; Kaminer, 
2008; Deas & Thomas, 2001; Galanter & Kleber, 2008). Family-based approaches 
on the other hand may be equally effective. Family therapy encompasses a range of 
different interventions with varying theoretical sources, including behavioral and 
cognitive behavioral theory, structural and strategic family theory, and family 
systems theory (Williams et al., 2000; Austin et al., 2005). Some reviews have 
suggested that these family-based therapies are superior to individual-based 
programs in reducing youth drug abuse (Williams et al., 2000; Lipsey, Tanner-
Smith, & Wilson, 2010; Waldron, 1997). 
Young people with persistent drug abuse have unique needs due to their particular 
cognitive and psychosocial development. Young people are especially sensitive to 
social influence, with family and peer groups being highly influential. Youth drug 
treatments which facilitate positive parental and peer involvement, and which 
integrate other systems in which the young person participates (such as schools, 
social services, and justice authorities) are thus key to reducing drug abuse by young 
people (NIDA, 2009). A number of studies and reviews have showed positive results 
for family therapies in general, but there is a need to synthesize individual study 
results for specific family therapies to determine whether and to what extent specific 
family therapy interventions work for young drug abusers (Williams et al., 2000; 
Austin et al., 2005; Waldron & Turner, 2008; Kaminer, 2008; Deas & Thomas, 
2001).  
This review is concerned specifically with Functional Family Therapy (hereafter 
FFT) (Alexander & Parsons, 1973; Alexander & Parsons, 1982; Rowe & Liddle, 
2003), as aggregated evidence for the effects of this approach is lacking. The review 
will seek to clarify the effects of the FFT program for relevant groups of young 
people aged 11-21, and will focus on young people enrolled in treatment for drug 
abuse, irrespective of how their problem is defined. Enrolment in treatment is taken 
to imply that the severity of the young person’s drug abuse has compelled a close, 
significant adult (for example, teacher, parent, social services, or school counselor) 
to demand that the young person enters treatment. FFT is an intervention offered as 
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an outpatient treatment2 to young people age 11-21 that are living with their 
families3.  
This review focuses solely on non-opioid drug abuse4, and is one in a series of 
reviews on manual-based family therapy interventions for young people in 
treatment for non-opioid drug abuse5. 
1.2  DESCRIPTION OF THE INTERVENTION 
Functional Family Therapy (FFT) is a short-term, manual-based, behaviorally 
oriented family therapy program for young people with behavior problems such as 
drug abuse, juvenile delinquency and violence. Delivered in an outpatient setting, it 
aims to help young people and their families by improving family interactions and 
relationship function by addressing dysfunctional individual behavior (Sexton & 
Alexander, 2000; Sexton & Turner, 2011). 
In an FFT program, the therapist provides intensive family therapy in an attempt to 
change the patterns of family interaction that are contributing to the problem 
behavior and to help family members develop specific skills in, for example, 
communication, conflict resolution, problem solving, and effective parenting. After 
the desired behavioral change has been achieved within the family, the therapist 
helps the family generalize changes to other situations and settings, such as school, 
community, and peers, and identifies support that can help to maintain the progress 
made (Sexton & Alexander, 2003; Onedera, 2006).  
As with many other forms of family therapy, FFT targets young people and their 
families as a system. As such, it recognizes the important role of the family system in 
the development and treatment of young people’s drug abuse problems (Ozechowski 
& Liddle, 2000); indeed, the FFT model asks that there be no ‘identified patient’. 
While a specific FFT intervention may focus on improving specific problems such as 
drug abuse, the FFT approach in itself adds a broader view of the change process 
and clinical outcomes by switching from an individual problem focus to a relational 
                                                        
2 A Cochrane review has evaluated psychosocial interventions for substance abuse and misuse in young 
offenders in locked facilities (Townsend et al., 2009). 
3 Technically, FFT requires only that the youth be residing with a caregiver for 6 months. 
4 Two Cochrane reviews have evaluated psychosocial treatments for treatment of opioid dependence 
(Amato et al., 2011; Minozzi et al. 2011). A further review (co-registered in Campbell and Cochrane 
Collaborations) on the effects of FFT for families with behaviour problems  (Littell et al., 2007) is in 
progress and has broader inclusion criteria. 
5 See the following Protocols in the Campbell Library: Brief Strategic Family Therapy (BSFT) for young 
people in treatment for  non-opioid drug use, (Lindstrøm et al.);  Family Behavior Therapy (FBT) for 
young people in treatment for non-opioid drug use (Kowalski et al.);  Multidimensional Family Therapy 
(MDFT) for young people in treatment for non-opioid drug use (Rasmussen et al.). 
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perspective. The intervention is designed to help families recalibrate their 
interaction patterns and improve family relations, and through this achieve 
individual goals such as decreased drug abuse (Alexander, Waldron, Robbins, & 
Neeb, 2013).  
FFT was developed in the late 1960s and early 1970s (Alexander & Parsons, 1973) 
with the model described in full by Alexander and Parsons in the early 1980s 
(Alexander & Parsons, 1982). It was developed to serve diverse populations of 
under-served and at-risk adolescents and their families because these populations 
lacked resources, were difficult to treat, and were often perceived by professionals as 
lacking the motivation for change. The founders of FFT realized that successful 
treatment of these populations required service providers who were sensitive to the 
needs of these diverse families, who were competent to work with them, and who 
understood why the families had traditionally resisted treatment (Sexton & 
Alexander, 2003). The development of the FFT program has continued, and the 
therapy has been refined in response to the results of research and the experiences 
from successful implementation (Alexander & Robbins, 2010).  
In a systematic review conducted by Austin et al. (2005), FFT appeared as one of 
five interventions identified as consistent with the majority of guidelines for effective 
treatment for adolescents with substance abuse. Austin et al. (2005) also note, 
however, that there is some inconsistency in the research on outcomes of FFT and 
that long-term follow-up assessment is needed. In a meta-analytical study, Waldron 
& Turner (2008) synthesized findings from 17 studies evaluating outpatient 
treatments for substance-abusing youth, including several therapy models, among 
them FFT, other family therapy approaches, group CBT, individual CBT and 
minimal treatment conditions. Waldron & Turner (2008) found that the effect size 
associated with reductions in drug abuse was significantly larger for family therapy 
relative to the minimal treatment condition, but the meta-analysis did not establish 
one of the treatment approaches as clearly superior to any other in terms of 
treatment effectiveness for substance-abusing youth. 
1.2.1  Theoretical background 
FFT is derived from both family system theory (Alexander & Parsons, 1973) and 
cognitive behavioral theory and techniques (Alexander & Robbins, 2010). The 
therapy focuses on family functioning, and is thus based on the premise that both 
positive and negative behavior can have a direct influence, and are influenced by 
multiple relational systems (Alexander & Sexton, 2002; Sexton & Alexander, 2000). 
It assumes that young people’s problem behavior can serve a function within the 
family. Family members develop ways of interacting that help them meet their 
relational needs for closeness or distance, but these patterns of interacting may also 
create or maintain behavioral problems. When changes are made in how the family 
interacts (by, for example, improving communication, problem-solving, and 
parenting skills), behavioral problems will be resolved. Interventions must take into 
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account the needs of each family member and be tailored to the family’s unique risk 
and protective factors (Alexander & Sexton, 2002; Sexton & Alexander, 2003; 
Alexander et al., 2013). 
While FFT is established as a distinctly unique approach, it has not emerged in a 
vacuum and is related to other current treatment approaches. Accordingly, Calley 
(2011) states that one of the most striking elements of the functional family therapy 
approach is its similarity to other therapeutic models, such as multisystemic family 
therapy, motivational enhancement therapy and solution-focused brief therapy. She 
emphasizes that this is not a deficit of the FFT model but rather a reminder of the 
evolutionary nature of the theories informing psychotherapy in general. Some of the 
characteristics that make FFT stand out are the emphasis on relational functions 
(hence the title Functional Family Therapy), the level of implementation of detailed 
treatment manuals and protocols for training and supervision, as well as the 
distinctive phase model (Alexander et al., 2013). Furthermore, FFT is a multi-
systemic treatment focusing on the multiple domains and systems of which the 
adolescent is part, such as the community, school and the juvenile justice system 
(Sexton & Alexander, 2003). Finally, FFT is a multilevel intervention in which the 
therapist works first to develop the family’s inner strengths and sense of being able 
to improve their situation. This provides a foundation for change and future 
functioning that extends beyond the direct support of the therapist and other social 
systems. As FFT is a strength-based model, its philosophy is that the intervention 
offers self-sufficiency through a platform for change for the family (Sexton & 
Alexander, 2000; Sexton & Turner, 2011). 
FFT therapists have diverse professional backgrounds. In one FFT intervention 
targeting youth with behavioral problems that was carried out in a community 
practice setting, the majority of therapists were Master’s degree clinicians; others 
were Bachelor’s level, and the therapists’ clinical experience ranged from 1 to 40 
years. Regardless of the variations in training and experience, all therapists received 
ongoing group-based FFT training, and outcome studies suggested that rather than 
the professional background, the decisive therapist characteristic was the level of 
treatment model adherence. Thus, the FFT intervention was found to be effective 
only when the therapists adhered to the treatment model (Sexton & Turner, 2011). 
In a previous study, undergraduate paraprofessionals trained in FFT produced 
significant reductions in recidivism rates among youth offenders (Barton, 
Alexander, Waldron, Turner, and Warburton, 1985), giving some indication of the 
level of training that might be required to successfully reproduce FFT (cf. Sexton 
2011). In general, the FFT model emphasizes the importance of ongoing training and 
supervision to maintain therapists’ model fidelity, and FFT provides training and 
supervision protocols to facilitate adherence in real-world settings (Alexander et al., 
2013). 
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1.2.2 FFT components 
As a clinical model, FFT is both flexible and structured: flexible because it requires 
individualized treatment strategies to be formulated by sensitive clinicians, and 
structured because it offers a fixed sequence of treatment strategies (Alexander & 
Sexton, 2002).  
The FFT treatment contains five interdependent and sequentially linked phases, in 
addition to pre-treatment and post-treatment activities. Each of the five phases has 
specific assessment and intervention components that are tailored to the unique 
characteristics of each family: (1) Engagement in change; (2) Motivation to change; 
(3) Relational/interpersonal assessment and change planning; (4) Behavioral 
Change; (5) Generalization across behavioral domains and multiple systems 
(Alexander & Robbins, 2010; Alexander et al., 2013).  
Research on FFT outcomes has emphasized investigations of the intervention’s 
effectiveness in relation to desired outcomes (Alexander et al., 2013 p. 37-62) rather 
than investigating possible adverse effects (Dishion, McCord, & Poulin, 1999) of 
FFT. Critics have suggested that future evaluations of FFT need to be carried out by 
a broader group of researchers to ensure rigorous evaluation of the approach in 
practice settings and to nuance the documentation of outcomes (Calley, 2011). 
Stressing desired outcomes at the expense of turning attention to the investigation 
of adverse effects is characteristic of much research into effects of psychotherapy, 
not just FFT (cf. Barlow, 2010). Nonetheless, research suggests that possible adverse 
effects of therapy include exacerbating clients’ problematic symptoms or initiating 
an experience of passive dependence (Dishion et al., 1999, Barlow, 2010). 
Pre-treatment Preparation and Engagement phase 
Before the therapist contacts the family, he or she will gather all information 
available about the youth and his or her family (including from formal assessments 
and official records). The ultimate goal of the Pre-treatment phase is that the 
therapist is fully ready both to assist the youth and family, and also to anticipate 
potential barriers and utilize strengths so that a positive experience for the family 
may be created (Alexander & Robbins, 2010; Onedera, 2006). 
The engagement phase involves activities that encourage the family to attend 
sessions. The therapist strives to create a positive contact with the family by, for 
example, scheduling appointments via telephone rather than by letter (this has the 
additional advantage of allowing the therapist to form a first impression of the 
family and to identify potential problems such as resistance to or confusion about 
treatment). It is considered important that the therapist be culturally competent and 
able to assist the family in feeling respected and comfortable (Alexander et al, 2013).  
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Motivation phase 
The goal of this phase is to create a positive and motivational context within which 
change can occur. Alexander (interview in Onedera, 2006) stresses that motivation 
is fundamental for subsequent behavioral change. It is considered important that 
any negativity is decreased in this early phase before targeting actual behavioral 
change; this is because negative emotions can prevent family members from making 
a realistic commitment to change (Onedera, 2006). Using a range of therapeutic 
techniques, the family members are helped to feel a reduction of blame, anger, and 
hopelessness and an increase in hopefulness (Alexander & Sexton, 2002; Sexton & 
Alexander, 2003).  
The phase consists of two major domains of activity: Changing Focus and Changing 
Meaning. ‘Change Focus interventions’ attempt to disrupt negativity and 
unproductive family interactions by shifting, stopping or redirecting 
communication. ‘Change Meaning interventions’  seek to change the meaning of 
how family members understand themselves and each other (Alexander & Robbins, 
2010; Alexander et al., 2013). 
Relational assessment 
The goals of relational assessment are to elicit and analyze information pertaining to 
relational processes, and to develop plans for the further process. 
Relational assessment focuses on two family relationship domains: (a) the degree of 
connection between members of the family, and (b) the hierarchical pattern involved 
in those connections. In this phase, the therapist identifies how to approach specific 
changes in the family to meet the least resistance and create the most lasting effects. 
Relational assessment provides a framework that addresses not only the specific 
problem behavior (e.g. youth drug abuse) but also the unique abilities and styles of 
the family members with respect to each other. The focus is directed to intra-family 
and extra-family capacities which include values, attributions, functions, interaction 
patterns, and sources of resistance (Alexander & Robbins, 2010; Alexander et al., 
2013). 
Behavior change 
In this phase, the main goals are to develop an implementation plan for change. It is 
important that the plan matches the unique family, each of its members, and their 
relational functions. The therapist provides concrete behavioral interventions to 
guide and model specific behavior changes (e.g. communication training, problem 
solving, negotiating, parental skills training, and conflict management). It is seen as 
important that the techniques used are individualized and developmentally 
appropriate, and that they fit the family relational system (Alexander & Sexton, 
2002; Alexander et al., 2013).  
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Generalization  
In the last phase, the goals are to generalize, maintain and support change by 
incorporating community resources. The aim is to encourage family members to 
solve their problems using the identified strengths and skills they have learned, and 
to reduce dependence on the therapist. Interventions seek to help the family to 
generalize across different situations, to be more efficacious in overcoming setbacks 
or relapse, and to use community resources. There is a focus on motivating the 
families to continue attending sessions after family life has improved whilst at the 
same time encouraging the family to rely on their own capacities. Community 
resources are actively mobilized in the generalization phase.  Behavior is seen as 
indicative of the functionality of the family system (Alexander & Sexton, 2002; 
Alexander & Robbins, 2010; Alexander et al., 2013). 
1.2.3 Duration and setting  
FFT is a short-term intervention comprising on average 8-12 sessions for mild cases 
and up to 30 sessions for more complex cases. The sessions are normally spread 
over a period of between three and six months. The therapist spends at least one 
hour per week with the youth and his or her family. The program is flexible and can 
be implemented in a variety of settings, including at a clinical or community facility 
or with in the family home (Sexton & Alexander, 2003). 
1.3  HOW THE INTERVENTION MIGHT WORK 
FFT was originally designed to aid in the family unit becoming healthier; a reduction 
in recidivism rates for juveniles and the treatment of substance use has subsequently 
grown out of the model, but was not a driving force in its design. Where FFT  is 
applied specifically to youth with non-opioid drug use problems, however, two 
rather different primary objectives can be discerned: 1) to eliminate or reduce young 
people’s drug abuse, and 2) to change behaviors associated with drug abuse in young 
people and their families. Randomized controlled trials and systematic reviews have 
indicated that FFT can reduce drug abuse in participants, can contribute to a 
reduction in behavioral problems and delinquency, and is associated with 
improvements in family communication patterns and relationships (Austin et al., 
2005; Waldron, Slesnick, Brody, Turner, & Peterson, 2001; Waldron & Turner, 
2008; Hogue & Liddle, 2009; Stanton & Shadish, 1997). 
Psychodynamic, behavioral, and social learning have been the key theories that 
shaped have FFT (Alexander et al., 2013). Fundamentally, this theoretical bedrock 
indicates that problem behavior is not approached as a mere reflection of individual 
psychopathology. Rather both positive and negative behavior is viewed in the social 
context, meaning that therapists focus their attention more on interactional 
dynamics. Furthermore, FFT is influenced by family systems and communication 
theories infusing the holistic perspective and implying that therapists view social 
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roles and relationships as central, if not causative, aspects of problem behavior 
(Alexander et al., 2013). Building on these theories, FFT requires that the therapists 
focus on the relational functions of all family members’ behaviors relevant to the 
problem behavior (e.g. drug abuse) of the referred youth. In other words, FFT 
theorizes that changing individual drug abuse may be achieved through improving 
family relations and reducing dysfunctional interaction. 
A basic premise of FFT is therefore that family members of the referred substance-
abusing youth participate in the treatment process. The decision about who is to 
participate in FFT sessions in a particular case is based on the therapist’s 
understanding of which family members will be important for the change process 
involving the referred youth (Alexander et al., 2013). While parents (or parental 
figures) are expected to participate, they are not necessarily expected to be 
motivated at the treatment outset to keep the family integrated. Parents, especially 
stepparents, may enter FFT motivated to have the youth removed from the home, 
and FFT treatment encompasses specify strategies to engage them in a positive 
change process (Alexander et al., 2013). 
The program outcomes may be affected by mediating factors such as participant 
characteristics and program mechanisms. Participant characteristics that have been 
found to predict program drug abuse reduction or abstinence were: history and 
severity of drug abuse pretreatment; level of general peer and parental support, 
particularly in relation to non-drug use; and higher levels of school attendance and 
functioning pretreatment (Williams et al., 2000). More information is required by 
practitioners on the impact of other characteristics such as age, gender, ethnicity, 
family composition (e.g., single parenting), and co-occurring conditions. These 
participant characteristics are potential predictors of treatment outcome and 
practitioners need to be able to assess the program’s relevance for any particular 
type of client. 
Treatment variables with positive impacts on treatment outcomes have been 
identified in a number of reviews of a range of treatments for youth drug abuse 
(Waldron & Turner, 2008; Williams et al., 2000). Treatment completion is the 
variable most consistently related to reduction in drug abuse (Williams et al., 2000; 
Waldron & Turner, 2008). While it is established that building a therapeutic alliance 
early in treatment  increases the likelihood  that young people complete treatment 
and reduce their drug abuse (Waldron & Turner, 2008), it remains unclear whether 
this is a direct effect or an indicator of treatment motivation (which itself has been 
shown to have a positive impact on treatment outcome). Either way, these findings 
point to the importance of the FFT components of ‘engagement’ and ‘motivation’ as 
influences on treatment compliance and attendance.  
1.3.1 Intervention mechanisms 
The focus on family systems, the behavioral nature of the approach, and the 
requirement to address engagement and motivation issues are all possible 
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explanations of intervention impact. These mechanisms influence family behavior 
and functioning, and ultimately facilitate changes in young people’s drug abuse. 
In FFT, the Engagement component is the first step a therapist takes to prepare the 
family for change. This component stresses the importance of the therapist’s 
capacity to create a positive relation to all family members. The therapist prepares 
for the meeting with the family by gathering all available information about the 
youth and his or her family. The goal of this is to be culturally equipped to meet the 
family with respect to and to understand as much as possible about, the context.  
The Motivation phase is closely linked to the Engagement phase and contains a 
number of intervention techniques (e.g. ‘divert and interrupt’, ‘reframing’, and 
developing positive themes) which can be used by the therapist to gain change 
within the family. By using the intervention technique of ‘reframing’, the therapist 
creates alternative cognitive and attributional perspectives that help redefine 
meaningful events and thus reduce negativity. Reframing challenge clients to 
identify new directions for future change help to link family members to one 
another, so that each one feels a joint responsibility for the family’s struggles.  
Motivation, as key to positive treatment outcome (Williams et al., 2000), is also 
linked to the support and influence of the family system. The family system’s ability 
to influence the young person toward a non-drug-using lifestyle is a possible 
mechanism of change related to the family systems focus of FFT. Studies have found 
that FFT positively influences family interaction, and contributes to the reduction in 
young people’s drug abuse (Ozechowski & Liddle, 2000). 
Therapeutic alliances are described as crucial in the mechanisms of change 
associated with FFT. Within FFT, therapeutic alliances are associated with 
interventions delivered in a fashion whereby each family member 1) trusts the 
therapist and his/her expertise, 2) believes the therapist is working hard to respect 
and value them regardless of their behavior, 3) believes the therapist is working hard 
to understand their emotions and values (Robbins, Turner, Alexander, & Perez, 
2003). Research into the importance of therapeutic alliances suggests, that 
therapists who were able to achieve a balanced or similar level of alliances (i.e. 
avoiding unbalanced alliances in which therapists are more closely aligned with 
parents than youth or vice versa) were more likely to retain family in treatment 
(Robbins et al., 2003). These results underline the importance of the therapist’s 
success in creating a positive, balanced family-therapist alliance in the engagement 
and motivation phase. 
1.4  WHY IS IT IMPORTANT TO DO THIS REVIEW 
Persistent drug abuse among young people is a significant social problem, and the 
treatment of young people’s drug abuse is challenging and costly, not least because 
the treatments for such problems are plagued by high dropout rates and post-
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treatment relapse. Research suggests that nearly half of the young drug users who 
enter treatment never complete it (SAMHSA), 2008). There is a need to identify 
effective treatments that address young people’s drug abuse problems and that 
minimize dropout and post-treatment relapse. Furthermore, the growing interest 
among policymakers in increasing funding for evidence-based interventions was a 
strong motivation for collecting further evidence with a systematic review on a 
promising treatment for young drug users. 
By aggregating the results from all available individual studies on FFT, this review 
will contribute to the body of knowledge on the treatment of young drug-users and 
their families. The review will inform practice by exploring the effects of FFT for 
relevant client groups. 
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2 Objectives 
The main aim of this review is to evaluate the current evidence on the effects of FFT 
on drug abuse reduction for young people in treatment for non-opioid drug use. 
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3 Methods 
3.1  TITLE REGISTRATION AND REVIEW PROTOCOL 
The title for this systematic review was approved in The Campbell Collaboration on 
31 May, 2010. The review protocol was approved on 21 September 2014. Title and 
protocol are available at: http://campbellcollaboration.org/lib/project/173/. 
3.2  CRITERIA FOR CONSIDERING STUDIES FOR THIS 
REVIEW 
3.2.1 Types of studies 
Study designs eligible for inclusion were: 
Controlled trials6  where all parts of the study are prospective (i.e. recruitment of 
participants, assessment of baseline characteristics, allocation to intervention, 
selection of outcomes and generation of hypotheses, see Higgins & Green, 2008). 
These include: 
o randomized controlled trials (RCTs); 
o quasi-randomized controlled trials (QRCTs), where participants are 
allocated by means such as alternate allocation, person’s birth date, 
the date of the week or month, case number or alphabetical order; 
o non-randomized controlled trials (NRCTs), where participants are 
allocated by other actions controlled by the researcher, such as 
location difference or time difference.   
Given that the aim of this review was to be as comprehensive as possible, we justify 
including NRCT designs because they may contain relevant information that is not 
captured in RCTs. 
To be eligible for inclusion, NRCTs must have demonstrated pre-treatment group 
equivalence via matching, statistical controls, or evidence of equivalence on key risk 
                                                        
6 A controlled trial typically includes at least two groups, an intervention/experimental group and a 
control group, and outcome measures recorded pre- and post–treatment. 
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variables and participant characteristics. These factors are outlined in section 3.4.3 
under the subheading of Confounding, with the methodological appropriateness to 
be assessed according to the risk of bias model outlined in Section 10.2. 
We did not find any relevant quasi-randomized or non-randomized studies for 
inclusion in this review.  
3.2.2 Types of participants 
The population included in this review was young people aged 11-21 years who were 
enrolled in outpatient manual-based FFT treatment for non-opioid drug use. Non-
opioid drugs are defined as cannabis, amphetamines, ecstasy or cocaine. The misuse 
of prescription drugs and the use of ketamine, nitrous oxide and inhalants such as 
glue and petrol are not considered in this review. 
Definitions of young people, and the age at which someone is considered a young 
person and so entitled to special services such as drug treatment, varies 
internationally (United Nations, 2011). Age group distinctions for young people are 
unclear because the boundaries are fluid and culturally specific (Weller, 2006). 
Furthermore, young people start experimenting with illegal drugs at different ages 
in different countries (Hibell et al., 2009), and patterns of independence from 
parents and of independent living vary internationally.  In order to encapsulate 
these international differences we have set the age range from 11 to 21 years (Hibell 
et al., 2009; United Nations, 2011; SAMHSA, 2010; Danish Youth Council, 2011). 
This age range is consistent with the other Campbell reviews in this suite of  reviews 
on family therapies in the treatment of non-opioid drug use in young people, even 
though FFT is not intended as a treatment  for those over the age of 18. 
We included only out-patient interventions in order to evaluate the effects of FFT on 
youths living with their families, since family interactions are fundamental to FFT.  
We defined the population as young people referred to or in treatment for using 
non-opioid drugs. No universal international consensus exists on classifying drug 
users7, and a number of assessment tools and methods of classifying the severity of 
drug use have been applied in different research studies (American Psychiatric 
                                                        
7 Different systems classify clients into different categories, e.g., users, misusers and dependents. These 
specific categorizations are used in the Diagnostic and Statistical Manual of Mental Disorders (DSM) 
(American Psychiatric Association, 1994, 2000). While the DSM-IV is a widely used classification 
system, other relevant classification systems such as the International Statistical Classification of 
Diseases and Related Health problems (ICD, currently ICD-10) developed by the World Health 
Organisation (WHO) are also in wide use. Differences between the classification systems concern both 
terminology and categorization criteria. For example, the DSM-IV includes the category ‘abuse’, while 
the ICD-10 explicitly avoids this term on the grounds of its ambiguity; harmful use and hazardous use 
are the equivalent terms in WHO usage, but the categories are not identical: while the ICD-10 solely 
operates with physical and mental criteria,  the DSM-IV also includes social criteria (WHO, 2011; 
Nordegren, 2002). 
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Association, 2000; World Health Organization (WHO), 2011; Nordegren, 2002). We 
included participants regardless of any formal drug use diagnosis. The main 
criterion for inclusion was that the young person was enrolled to participate in the 
treatment (intervention or comparison condition). Referral to and enrolment in 
drug use treatment suggests a level of drug use such that a significant other or 
authority (or the young person themselves) has found it necessary to seek treatment. 
It is evident in the literature that there are various reasons why young people 
become enrolled in drug treatment programs, including FFT. One is that there is 
clear evidence of drug use, either observed or self-reported; another is that the 
young person is seen as being at significant risk of using drugs by nature of his/her 
environment or peer group. Given this complexity, the fact that an individual may 
fall into more than one of these groups, and the inherent difficulty in determining 
accurately the proportion of non-opioid drug users in any sample of young people, 
we included studies where at least 50% of participants had either used or were 
suspected of using drugs, and the rest of the sample were at risk for drug use 
through having peers that do so.   
We included poly-drug users only if the majority of participants in a study used non-
opioid drugs. Psychosocial interventions for youth opioid dependence has been 
evaluated in Cochrane reviews (Amato et al., 2011; Minozzi et al., 2011) and we 
wished to avoid duplication of effort.  We excluded populations who exclusively used 
alcohol. 
3.2.3 Types of interventions 
The review included outpatient manual-based FFT interventions of any duration 
delivered to young people and their families (see 1.2 Description of the 
intervention). The FFT intervention must have been delivered in an outpatient 
setting and not include overnight stays in a hospital or another treatment facility. 
The FFT intervention could have taken place in the home, at a community center, in 
a therapist’s office or at an outpatient facility.  Interventions in restrictive 
environments, such as prisons, detention centers, institutions for sentence-serving 
juvenile delinquents or other locked institutions8  were excluded. 
FFT is a family intervention requiring active participation by the young drug user 
and his or her family, with one of the primary aims being the improvement of family 
functioning. In cases where the young drug user is placed outside the family home, 
as with inpatient treatment or incarceration in a locked facility, the core condition of 
the program would be seriously compromised. 
                                                        
8 A Cochrane review has evaluated psychosocial interventions for substance abuse and misuse in young 
offenders in locked facilities (Townsend et al., 2009). 
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Studies where FFT was delivered with add-on components were included as long as 
FFT was the primary intervention.  
Eligible comparison conditions were no intervention, waitlist controls and 
alternative interventions including Treatment as Usual (TAU) as we are interested in 
both absolute and relative effects.  Due to ethical considerations and the nature of 
the problem (i.e. young peoples’ drug use), the likelihood of finding a no treatment 
control condition was considered small. We expected that the most frequent 
comparison condition would be alternative interventions (Lipsey et al., 2010).  
3.2.4 Types of outcome measures 
We considered the following outcomes: 
Primary outcome(s)  
Abstinence or reduction of drug use, as measured by (for example):  
 Biochemical test (e.g. urine screening for drug use);  
 Self-reported estimates of drug use (e.g. Timeline Followback TLFB; 
Sobell & Sobell, 1992);  
 Psychometric scales (e.g. Addiction Severity Index; McLellan, Luborsky, 
Woody & O’Brien, 1980). 
Secondary outcomes  
 Family functioning (e.g. as measured by the Beavers Interactional 
Competence Scale; Beavers & Hampson, 2000). 
 Education or vocational involvement (e.g. as measured by grade point 
average, attendance, self-reported or reported by authorities, files, 
registers, or employment record). 
 Treatment retention (e.g. as measured by days in treatment, completion 
rates and/or attrition rates). 
 Risk behavior, such as crime rates, prostitution (e.g. as measured by self-
reports or reports by authorities, administrative files, registers). 
 Other adverse health outcomes (e.g. as measured by length and 
frequency of hospitalization, suicide and overdose).  
The primary outcome is abstinence or reduction of drug use, as the main review 
objective is to evaluate current evidence on FFT’s effects on drug use reduction for 
young people in treatment for drug use. We were seeking evidence on how to best 
reduce or eliminate drug use as drug use is understood as the young people’s 
primary problem.  
Outcomes were considered over the following intervals: 
 Short term (end of treatment to less than 6 months after end of 
treatment)  
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 Medium term (6 to 12 months after end of treatment) 
 Long term (more than 12 months after end of treatment) 
3.3  SEARCH METHODS FOR IDENTIFICATION OF STUDIES 
The search was performed by one of the review authors (AKJ) 
3.3.1 Electronic searches 
Relevant studies were identified through electronic searches of bibliographic 
databases, government and policy databanks. No language or date restrictions were 
applied to the searches. 
The following bibliographic databases were searched: 
Bibliotek.dk searched until July 2, 2013 
Bibsys searched until July 2, 2013 
Cinahl (EBSCO) searched on until July 2, 2013 
Cochrane Library searched until June 12, 2013   
Criminal Justice Abstracts (EBSCO) searched until July 2, 2013 
Embase (Ovid) searched until July 2, 2013 
ERIC (EBSCO) searched until July 2, 2013 
Libris searched until July 2, 2013 
Medline (Ovid) searched until July 2, 2013   
PsycINFO (EBSCO) searched until June 12, 2013 
Science Citation Abstract searched until July 2, 2013  
Social Care Online searched until July 2, 2013 
Social Science Citation Abstract searched until July 2013 
Socindex searched until July 2, 2013  
3.3.2 Search terms 
An example of the search strategy for MEDLINE searched through the Ovid 
platform is listed below. This strategy was modified for the different databases (see 
section 10.4 for details). 
1. FFT.af. 
2. Famil* adj1 Functional* adj1 therap*.af. 
3. 1-2/or 
3.3.3 Searching other resources 
The review authors checked the reference lists of other relevant reviews and each of 
the included primary studies for new leads.  We identified 16 leading international 
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experts who had published in this subject area, and contacted them individually in 
attempt to identify unpublished and ongoing studies. We provided the experts with 
the inclusion criteria for the review along with the list of included studies, asking for 
any other published, unpublished or ongoing studies relevant to the review.  
3.3.4 Hand search 
The following five international journals were hand searched for relevant studies: 
 Addiction 
 Journal of Consulting and Clinical Psychology 
 Journal of Substance Abuse Treatment 
 Journal of Clinical and Adolescent Psychology 
 Research on Social Work Practice 
Searching was performed on journal editions from January to September 2013 in 
attempt to identify any recently published studies that may not have been found in 
the systematic search.  
3.3.5 Grey literature  
Additional searches for relevant studies and useful leads were made using Google 
and Google Scholar, where we checked the first 150 hits.  OpenGrey 
(http://www.opengrey.eu/) was used to search for European grey literature. Copies 
of relevant documents were made and we recorded the exact URL and date of access 
for each relevant document. DissExpress was searched in attempt to identify any 
relevant dissertations. 
In addition, we searched the following sites for relevant ongoing or unpublished 
research projects and useful leads:  
National Institute on Drug Abuse (NIDA) http://www.nida.nih.gov/nidahome.htm  
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) 
http://www.emcdda.europa.eu/index.cfm 
Substance abuse and Mental Health Services administration (SAMHSA) 
http://www.samhsa.gov/ 
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3.4  DATA COLLECTION AND ANALYSIS 
3.4.1 Selection of studies 
Two members of the review team9 independently screened titles and available 
abstracts to exclude studies that were clearly irrelevant under the supervision of 
ML10 (TLF & LH). Studies considered eligible by at least one reviewer was retrieved 
in full text. The full texts were then screened by two members of the review team 
(ML & DLS) to determine study eligibility based on the inclusion criteria. Any 
disagreements about eligibility were resolved by discussion. The study inclusion 
screening sheet was piloted and adjusted as required and was used throughout 
screening. The overall search and screening process is illustrated in a flow-diagram 
(Figure 11.1). 
3.4.2 Data extraction and management 
Two members of the review team (ML & SKN) independently coded the included 
studies. Information was extracted on: characteristics of participants, intervention 
characteristics and control conditions, research design, sample size, outcomes and 
results (the codebook can be found in Appendix 10.1). Extracted data were stored 
electronically. 
3.4.3 Assessment of risk of bias in included studies 
We assessed the methodological quality of studies using a risk of bias model 
developed by Prof. Barnaby Reeves in association with the Cochrane Non-
Randomised Studies Methods Group (Reeves, Deeks, Higgins, & Wells, 2011) 11. This 
model, an unpublished extension of the existing Cochrane Collaboration’s risk of 
bias tool (Higgins & Green, 2008), covers both risk of bias in RCTs and in NRCTs 
that have a well-defined control group.   
The extended model is organized and follows the same steps as the existing Risk of 
Bias model according to the Cochrane Hand book, chapter 8 (Higgins & Green, 
2008). The extension to the model is explained in the three following points: 
1) The existing Cochrane risk of bias tool needs elaboration when assessing non-
randomized studies because, for non-randomized studies, particular attention must 
be paid to selection bias/risk of confounding. The extended model therefore 
                                                        
9 Maia Lindstrøm, Therese Lucia Friis, Louisa Henriksen, Dorte Laursen Stigaard, Majken Mosegaard 
Svendsen and Anne-Sofie Due Knudsen are members of the review team.  
10 Maia Lindstrøm, author of the protocol of this review. 
11 This risk of bias model was introduced by Prof. Reeves at a workshop on risk of bias in non-
randomized studies at SFI Campbell, February 2011. The model is developed by the Cochrane Non-
Randomized Studies Method Group (NRSMG). 
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specifically incorporates a formalized and structured approach for the assessment of 
selection bias in non-randomized studies12 by adding an explicit item about 
confounding (Reeves et al. 2011). It is based on a list of confounders considered 
important and defined in the protocol for the review. The assessment of 
confounding is made using a worksheet where for each confounder it is marked 
whether the confounder was considered by the researchers, the precision with which 
it was measured, the imbalance between groups and the care with which adjustment 
was carried out. This assessment will inform the final risk of bias score for 
confounding. 
2) Another feature of non-randomized studies that make them at greater risk of bias 
compared to RCTs is that RCTs must have a protocol in advance of starting to recruit 
whereas non-randomized studies need not. The item concerning selective reporting 
therefore also requires assessment of the extent to which analyses (and potentially 
other choices) could have been manipulated to bias the findings reported, e.g., 
choice of method of model fitting, potential confounders considered/included. In 
addition the model includes two separate yes/no items asking reviewers whether 
they think the researchers had a pre-specified protocol and analysis plan. 
3) Finally the risk of bias assessment is refined, making it possible to discriminate 
between studies with varying degrees of risk. This refinement is achieved with the 
addition of a 5-point scale for certain items (see the following section Risk of bias 
judgment for details).  
The refined assessment is pertinent when thinking of data synthesis as it 
operationalizes the identification of studies (especially in relation to non-
randomized studies) with a very high risk of bias. The refinement increases 
transparency in assessment judgments and provides justification for not including a 
study with a very high risk of bias in the meta-analysis. 
Risk of bias judgment items and assessment 
The risk of bias model used in this review is based on 9 items (see section 10.2 for 
Risk of Bias tool). 
The 9 items refer to   
 sequence generation (Judged on a low/high risk/unclear scale – 
NRCT will automatically have high risk of bias ) 
 allocation concealment (Judged on a low/high risk/unclear scale)  
 confounders (Judged on a 5 point scale/unclear, only relevant for 
non-randomized studies, i.e. NRCT)  
                                                        
12 The extended model was developed to ensure standardization of guidelines and procedures in the 
Risk of Bias assessment of NRS.  
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 blinding (Judged on a 5 point scale/unclear)  
 incomplete outcome data (Judged on a 5 point scale/unclear)  
 selective outcome reporting (Judged on a 5 point scale/unclear)  
 other potential threats to validity (Judged on a 5 point 
scale/unclear ) 
 a priori protocol (Judged on a yes/no/unclear scale) 
 a priory analysis plan (Judged on a yes/no/unclear scale) 
The assessment was based on pre-specified questions (see section 10.2). “Yes” 
indicates a low risk, “No” indicates a high risk of bias, and “Unclear” indicates an 
unclear or unknown risk of bias. In the 5 point scale 1 corresponds to No/Low risk of 
bias (e.g., 1 = a high quality RCT) and 5 corresponds to Yes/High risk of bias (e.g., 
5= too risky, too much bias, e.g., a poor quality study).  A judgment of 5 points on 
any of the items assessed translates to a risk of bias so high that the findings would 
not be considered in the data synthesis (because they are more likely to mislead than 
inform) (see section 10.2). None of the included studies in the review or parts 
thereof were judged 5 on the risk of bias scale.  
Confounding was not relevant in the review since we did not find any NRCTs 
meeting the inclusion criteria.  
Assessment 
Two members of the review team (ADK & MMS) independently assessed the risk of 
bias for each included study and these were checked by a review author (TF). We 
report the results of this assessment in risk of bias tables for the two included 
studies (see section 9.3).  
3.4.4 Measures of treatment effect 
Standardized mean differences (SMD) were used as the effect size metric for drug 
use and risk behavior; the data used for these calculations were means, standard 
deviations and sample size. RevMan 5.0 and Excel software were used for storing 
data and statistical analyses.. 
3.4.5 Unit of analysis issues 
We planned to take into account the unit of analysis of the studies to determine 
whether individuals were randomized in groups (i.e. cluster randomized trials), 
whether individuals may have undergone multiple interventions, whether there were 
multiple treatment groups, and whether there were multiple publications for some 
studies. 
Cluster randomized trials 
If any cluster randomized trials had been identified we would have checked for 
consistency in the unit of allocation and the unit of analysis, as statistical errors can 
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occur when they are different. When suitable cluster analysis is used, effect 
estimates and their standard errors can be meta-analyzed (Higgins & Green, 2008). 
If we had found cases where study investigators had not applied appropriate 
analysis methods controlling for clustering, we would have approximated the intra-
cluster correlation (see Donner, Piaggio, & Villar, 2001) and corrected standard 
errors. 
Multiple interventions per individual  
If any studies with multiple interventions per individual were identified, they would 
have been reported separately. 
Multiple intervention groups 
All possible comparisons from studies with multiple intervention/control groups 
were analysed.   
Multiple publications 
A total of two unique studies, reported in three papers, were included in the review.  
Multiple time points and outcomes 
All follow-up durations reported in the primary studies were recorded. When 
reporting separately by time point, there were no remaining dependencies within 
each of those time points. 
3.4.6 Dealing with missing data 
The review authors assessed missing data and attrition rates for the included 
studies. In cases of missing data (e.g. valid Ns, means and standard deviations), we 
contacted the primary study authors, but received no reply13. We recorded attrition 
rates and (when possible) reasons for attrition from included studies. Information 
on intention to treat analysis (ITT) were also recorded.  
3.4.7 Assessment of heterogeneity 
We planned to assess statistically significant heterogeneity among primary outcome 
studies with the Chi-squared (Q) test, tau-squared and I-squared statistics (Higgins 
& Green, 2008). A significant Q or tau-squared (P<.05) and I-squared greater than 
50 percent would have been considered as indicating statistical heterogeneity. 
                                                        
13One author could not be located and the other author was contacted for missing data in May 2013. 
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3.4.8 Assessment of reporting biases 
Reporting bias refers to both publication bias and selective reporting of outcome 
data and results. Selective reporting was dealt with in the risk of bias assessment 
and any concerns reported in section 4.3.5. Had we found sufficient studies, we 
would have used funnel plots for information about possible publication bias 
(Higgins & Green, 2008).  
3.4.9 Data synthesis 
If studies had been coded with a very high risk of bias on an item (5 on the risk of 
bias scale) they would not be included in the data synthesis. Analysis of the absolute 
effects of FFT would have involved comparing FFT to no treatment and to untreated 
wait list controls.  
The relative effects of FFT (versus other interventions) were reported from studies 
that compared FFT to alternative interventions. All follow-up durations reported in 
the primary studies were recorded and we report separate results for all time points 
reported in the studies. 
We planned to pool results from primary studies based on outcomes and perform 
meta-analysis with inverse variance weighting using random effects statistical 
models that incorporate both the sampling variance and between-study variance 
components into the study level weights. We planned to use a random effects model 
to represent the overall effect since we expected the studies to deal with diverse 
populations of participants.  
We report SMDs and 95 percent confidence intervals in section 4.4. 
3.4.10 Analysis of heterogeneity 
We planned to investigate the following study-level covariates where possible with 
the aim of explaining observed heterogeneity: intervention characteristics (e.g., 
treatment duration, treatment intensity), participants’ characteristics (e.g., gender, 
age, family composition, ethnicity, co-morbidity, and history of drug use) and 
comparison intervention characteristics. 
If the number of included studies had been sufficient (dependent on the spread of 
the study means of the covariates and study sizes, (see Borenstein, Hedges, Higgins, 
& Rothstein, 2009; Simmonds & Higgins, 2007), we planned to perform moderator 
analyses (meta-regression) to explore how observed variables were related to 
heterogeneity using a mixed model. Otherwise, single factor subgroup analysis was 
planned. 
3.4.11 Sensitivity analysis 
Sensitivity analysis were planned to evaluate whether the pooled effect sizes were 
robust across study design and components of methodological quality. For 
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methodological quality, we planned to consider sensitivity analysis for each major 
component of the risk of bias checklists. To check for the possible influence of 
developer bias on effect sizes, we planned to run a sensitivity analysis to compare 
those studies conducted by program developers with studies conducted by 
independent researchers.  Developer bias can occur in studies conducted by the 
intervention developers who unconsciously influence the success of an intervention 
(Petrosino & Soydan, 2005; Eisner, 2009; Sherman & Strand, 2009).  
We also planned to perform sensitivity analysis for program fidelity, i.e., compliance 
with program manual and requirements for therapist training. 
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4 Results 
4.1  RESULTS OF THE SEARCH 
We ran the main searches in June 2013. We searched 14 international and Nordic 
bibliographic databases, performed an extensive search for grey literature, and hand 
searched five core journals in October 2013 (see section 3.3). 
After excluding duplicates, we found 6719 potential relevant records from the 
database search (bibliographic databases, 4343; grey literature, 725; hand searches 
and others, 1,651  
All 6719 records were screened based on title and abstract, and 108 records were 
retrieved and screened in full text. Of these, 93 did not fulfill the screening criteria 
and were excluded. 
Three papers met the inclusion criteria and were data-extracted by the review’s 
authors.  
A total of two unique studies, reported in three papers, were included in the review. 
Further details of the included and excluded studies are given in section 9. 
4.2  DESCRIPTION OF THE STUDIES 
4.2.1 Included studies 
Two studies met our inclusion criteria: 
Waldron et al. (2001) 
This is an RCT on the effects of individual cognitive-behavioral therapy (CBT), 
family therapy (FFT), combined individual and family therapy (CBT and FFT), and a 
group intervention for drug-using Hispanic and Anglo American youths aged 13-17, 
performed in New Mexico, USA. The study is reported in two articles: Waldron et al. 
(2001) evaluated the trial and reported the treatment outcomes related to drug use 
at 4 – and 7-month assessments, and was published in the Journal of Consulting 
and Clinical Psychology in 2001. French et al. (2008) attempted a cost-effectiveness 
analysis of the randomized clinical trial conducted by Waldron et al. (2001), and was 
published in the Journal of Substance Abuse Treatment in 2008. The main article is 
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by Waldron et al. (2001). The cost-effectiveness study by French et al. (2008) is 
included in this review as it provides outcomes different from the main article. Even 
though the study reported on a four-armed trial, we were only able to use the CBT, 
the group intervention and FFT groups because the joint intervention included both 
CBT and FFT.  
Friedman (1989) 
This is an RCT of drug-using youths aged 14-21 comparing functional family therapy 
(FFT) and a parent group method. It was performed at six different sites across the 
US and was published in The American Journal of Family Therapy in 1989.  
Location  
Both studies were carried out in the US. Waldron et al. (2001) took place at The 
University of New Mexico Center for Family and Adolescent Research. Friedman 
(1989) was conducted in six different “drug free” outpatient drug treatment 
programs.  
Design  
Both included studies were described by the investigators as RCTs. Both were 
randomized by family.  
Sample size 
Waldron et al. (2001) randomized 120 participants; 30 to FFT, 31 to CBT, 30 to the 
group intervention, and 29 to CBT and FFT combined. These numbers reflect the 
sample sizes at the point of randomization (not at recruitment or completion).  
Reported sample sizes in Friedman (1989) are 135 participants; 85 in FFT, and 50 in 
the parent group method. These numbers reflect the sample sizes at the point of 
follow up. Friedman (1989) reported that 169 families started in treatment, but the 
numbers randomized were not reported.  
Participants 
Participants in the two studies were aged between 13-21 years. The majority were 
male, ranging from 60 to 80 percent of the study population. Approximately half of 
the participants lived with both parents. Ethnicity varied between studies; almost all 
participants were white in Friedman (1989), and nearly half the participants in 
Waldron et al. (2001) were Hispanic. Main drug used in both studies was marijuana. 
The average number of years of education was 9.3. 
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Participant characteristics 
 Waldron et al. 
(2001) 
Friedman 
(1989) 
Age range (Mean), years 13-17 (16) 14-21 (17,9) 
Gender, males 80% 61% 
Family composition, single parent  45% 44% 
Family composition, two parent  55% 50% 
Family composition unknown 0% 7% 
Ethnicity, White 38% 90% 
Ethnicity, Hispanic 47% - 
Ethnicity, Other1 15% 10% 
Main drug used Marijuana Marijuana 
Years of education 9.3 9.3 
  1: Friedman (1989) report percentages for white/nonwhite only 
Inclusion criteria in included studies 
Inclusion criteria in Waldron et al. (2001) were that participants needed to be aged 
13-17 years, living at home with a primary caretaker who was also willing to 
participate, and meeting diagnostic criteria for a primary substance abuse disorder. 
Inclusion criteria were not reported in Friedman (1989). 
Exclusion criteria in included studies 
Waldron et al. (2001) excluded youths abusing only alcohol and/or tobacco. Youths 
and families were also excluded if the adolescent needed services other than 
outpatient treatment, if there was evidence of psychotic or an organic disorder, or if 
a sibling was participating in the study. Exclusion criteria were not reported in 
Friedman (1989). 
Experimental interventions  
FFT was the experimental intervention in both included studies. 
Comparison conditions 
The comparison condition in Friedman (1989) was a parent group method in which 
the adolescent clients were not included. They were given individual drug 
counseling. 
The study by Waldron et al. (2001) included two eligible comparison conditions; 
cognitive-behavioral therapy (CBT), and a group intervention. 
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Time points for measurements 
Time points for measurement were 15 month follow-up (6 months treatment, 9 
months follow-up period) in Friedman (1989) and 4 and 7 months following 
initiation of treatment (1 and 4 months post treatment) in Waldron et al. (2001) 
Primary outcome 
Only Waldron et al. (2001) reported on the primary outcome of youth drug use. This 
was reported as percentage of days of use, measured using the ‘The timeline follow 
back interview’. 
Secondary outcome  
Few secondary outcomes were reported. 
Education or vocational involvement 
A measure of education or vocational involvement was reported in Friedman (1989) 
as:  ‘Change that the Mothers Reported in the Clients’ Academic Problems’. 
Risk behaviour 
Risk behaviour measured as “Delinquency”/“Any delinquency”, based on The Youth 
Self-Report delinquency subscales, was used in the study by Waldron et al. (2001) 
and reported in French et al. (2008). 
4.2.2 Excluded studies 
Six studies which initially appeared to be eligible were excluded. The primary reason 
for exclusion of four of these studies is that participants were not in outpatient drug 
treatment primarily for non-opioid drug use. The remaining two studies focused on 
the comparison between ethnic matching of therapist and client respectively on the 
therapeutic alliance. The full characteristics of excluded studies are given in section 
9.2. 
4.2.3 Studies awaiting assessment 
A search of the clinicaltrials.gov database revealed two potentially relevant studies 
that are ongoing. These are listed in Table 9.5.   
4.3  RISK OF BIAS IN INCLUDED STUDIES 
4.3.1 Sequence generation 
Both included studies were described as randomized by the trial investigators. 
Waldron et al. (2001) reported the procedure for randomization and was judged as 
having a low risk of bias for sequence generation. Friedman (1989) did not report 
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the randomization procedure and was therefore judged as having an unclear risk of 
bias on this domain. 
4.3.2 Allocation concealment 
Neither of the two studies reported how allocation was handled, and both were 
therefore judged as having an unclear risk on this domain. 
4.3.3 Confounders 
This item is only relevant for non-randomized studies and consequently was not 
assessed. 
4.3.4 Blinding 
This item was judged on a 5 point scale/unclear in accordance with the risk of bias 
tool described in section 3.4.3. As is common in social interventions, and especially 
when outcomes are self-reported, there is an inherent risk of bias given the 
impossibility of blinding the participants or those delivering the interventions. Both 
studies were rated as unclear for blinding of outcome assessors because of lack of 
reporting on data collection and blinding procedures. 
4.3.5 Incomplete outcome data 
This item was judged on a 5 point scale/unclear in accordance with the risk of bias 
tool described in section 3.4.3. Dropout rates were reported in both studies, but only 
Waldron et al., (2001) performed analysis for any imbalance in attrition between 
groups. Waldron et al. (2001) was rated 1 for incomplete outcome data with respect 
to the outcomes “abstinence or reduction of drug use” and ‘unclear’ with respect to 
the outcome “risk behavior”. Friedman (1989) only reported on ‘education or 
vocational involvement ‘ and was rated 3 for incomplete outcome data. 
4.3.6 Selective reporting 
The study by Friedman (1989) was rated 4 due to no reporting of outcome results 
except for ‘Education or vocational involvement’. The trial investigator stated that 
there was no difference between the two groups with respect to number of sessions 
attended, but no numbers were provided. Waldron et al. (2001) was rated 1 with 
respect to the outcomes “abstinence or reduction of drug use” and “risk behavior” 
because these outcomes were reported carefully. However, the outcome “family 
functioning” in this study was rated 3 because the numeric data was missing. 
4.3.7 Other potential sources of bias 
His item was judged on a 5 point scale/unclear in accordance with the risk of bias 
tool described in section 3.4.3. In this part of the risk of bias tool we paid special 
attention to how the trial investigators measured treatment adherence. The study by 
Friedman (1989) was rated 3 because only the therapist adherence for the FFT 
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condition was measured. Waldron et al. (2001) was rated 1 because they addressed 
treatment adherence and report that a high adherence was achieved. 
4.3.8 A priori protocol 
Explicitly stating a priori hypotheses and methods without prior knowledge of 
results minimizes bias. The studies did not report whether an a priori protocol was 
produced and if so, whether it was followed. 
4.3.9 A priori analysis plan 
The studies did not report whether an a priori analysis plan was produced and if so, 
whether it was followed. 
4.4  EFFECTS OF THE INTERVENTIONS 
The two included studies both analyzed relative effects, comparing FFT to other 
interventions. A table with all numerical results can be found in section 9.4. 
4.4.1 Primary outcome results 
Drug use reduction was measured by percent of days of marijuana use in Waldron et 
al. (2001). The reported results indicate a positive effect favoring FFT on drug use 
frequency at 4-month follow up; SMD=0.78 (95% CI 0.25, 1.31) compared to CBT, 
and SMD=0.97 (95% CI 0.44, 1.51) compared to the group intervention.  
The percent of days of marijuana use was not significantly different for the 7-month 
follow up; SMD=0.28 (95% CI -0.23, 0.79) compared to CBT, and SMD=0.04 (95% 
CI -0.46, 0.55) compared to the group intervention. 
Numerical outcome results were not available in Friedman (1989). 
4.4.2 Secondary outcome results 
Family functioning and treatment retention was not reported in either of the 
included studies.  
Educational or vocational involvement 
Friedman (1989) reported results from a multiple regression equation (including 19 
covariates), comparing the two interventions on the change that mothers reported in 
the clients’ academic problems. There was no significant difference between groups. 
An F-value of 2.91, a p-value  of 0.093 and a change in R2  of 0.03 were reported.   
Risk behavior 
The study by Waldron et al. (2001) measured risk behavior using the delinquency 
subscale from the Youth Self Report (YSR) with the results reported in French et al., 
2008. Results are mixed, indicating a positive effect favoring FFT at 4-month follow 
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up; SMD=0.55 (95% CI 0.04, 1.06) compared to CBT, and no significant difference 
with SMD=0.37 (95% CI -0.14, 0.8) compared to the group intervention.  
No significant differences between groups were found for the 7-month follow up; 
SMD=0.28 (95% CI -0.23, 0.79) compared to CBT, and SMD=0.04 (95% CI -0.46, 
0.55) compared to the group intervention. 
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5 Discussion 
5.1  SUMMARY OF MAIN RESULTS 
Our main objective was to evaluate the current evidence on the effect of FFT on drug 
use reduction for young people in treatment for non-opioid drug use.  
Only one study provided data on drug use: this indicated a positive relative effect 
favoring FFT in comparison to CBT and a group intervention on drug use frequency 
at 4-month follow up, but no significant relative effect for the 7-month follow up.  
Only one study reported results on education, comparing FFT and a parent group 
intervention on the change that mothers reported in the clients’ academic problems. 
There was no significant difference between groups. 
One study reported on delinquency. Results were mixed, indicating a positive 
relative effect favoring FFT at 4-month follow up compared to CBT, but no 
significant difference compared to the group intervention.  
No significant relative effects of FFT were found for the 7-month follow up, 
compared to CBT or compared to the group intervention. 
No studies reported on family functioning or retention. It was not possible to assess 
moderators of drug use reduction effects, or whether FFT works better for particular 
types of participants. 
In short, we found there is currently insufficient evidence for conclusions to be 
drawn. The small number of available studies precludes any conclusions concerning 
effectiveness, ineffectiveness or potential damage of FFT for young people in 
treatment for non-opioid drug use.  
5.2  OVERALL COMPLETENESS AND APPLICABILITY OF 
EVIDENCE 
We found only two trials that examined whether FFT reduced youth drug use. Both 
studies were performed in the US. It was not possible to analyze the absolute effects 
of FFT as both studies compared FFT to other active treatments. Only one of the 
studies reported on the primary outcome of drug use reduction. Data on secondary 
outcomes were very limited.  
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It is important to consider program fidelity (i.e., compliance with program manual 
and requirements for therapist training) when evaluating the effects of an 
intervention such as FFT. Waldron et al., 2001, addressed treatment fidelity and 
reported that high adherence was achieved (see section 9.3 for a description of the 
method used). Friedman, 1989, considered the degree of adherence to the manual 
concerning the FFT intervention and reported that 3 percent of the therapist 
interventions were considered to be inconsistent with the functional method as 
described in the manual achieved (see section 9.3 for a description of the method 
used). A measurement of adherence to the parent group condition was not reported. 
5.3  QUALITY OF THE EVIDENCE 
Both studies were randomized controlled trials, although neither could be 
characterized as a robust RCT with low risk of bias on all assessed risk of bias items. 
The two included studies provided insufficient information on core issues to allow us 
to assess the risk of bias (e.g. allocation concealment and number of participants 
randomized) despite genuine efforts to contact the study authors. These 
methodological weaknesses may reflect inadequate reporting, flawed methodology, 
or both, and therefore compromise our confidence in the validity of the two studies.  
5.4  LIMITATIONS AND POTENTIAL BIASES IN THE REVIEW 
PROCESS 
The narrow search strategy performed in this review may limit the likelihood of 
identifying all relevant studies. However, we attempted to minimize the risk of 
missing relevant studies by conducting an extensive search of the grey literature, by 
extensive hand searching and by contacting international experts within the field. 
Indeed, the large number of grey literature and hand searches literature that has 
been assessed for relevance attests to this effort. 
5.5  AGREEMENTS AND DISAGREEMENTS WITH OTHER 
STUDIES OR REVIEWS 
The majority of the identified narrative reviews (Waldron & Turner, 2008; Vaughn 
& Howard, 2004; Austin, 2005; Ozechowski & Liddle, 2000) report that FFT-
treatment shows evidence of positive effectiveness in drug use among youth. This is 
predominantly consistent with the current reviews results, although our confidence 
in these results is limited. 
Two reviews (Waldron & Turner, 2008; Vaughn & Howard, 2004) include data on 
FFT from Friedman (1989) and conclude that FFT showed significant reductions in 
substance use of more than 50 % at follow up. Waldron & Turner (2008) classifies 
FFT as a well-established treatment for adolescent substance abuse based on 
Friedman (1989), Waldron et al. (2005) and Waldron & Slesnick et al. (2001).  
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Vaughn & Howard (2004) and Austin et al. (2008) indicate that youth participating 
in FFT demonstrated reductions in marijuana use from pre-treatment to post-
treatment. These findings are consistent with Ozechowski & Liddle (2000), who 
conclude that improvements in self-reported drug use from intake to 4 months post-
intake for FFT. 
Consistent with our expectations, most of the reviews (Waldron & Turner, 2008;. 
Vaughn & Howard, 2004; Austin et al., 2005; Ozechowski & Liddle, 2000;  Liddle, 
2004; James, Alemi & Zepeda, 2013; Lipsey et al., 2010) state that it is not possible 
to decide whether or not FFT is more effective than other interventions for 
decreasing drug use. The reviews recommend further research which can evaluate 
the influence of FFT on abuse treatment outcomes.  
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6 Authors’ Conclusions 
Even though reliable conclusions about the effectiveness of FFT are lacking, some 
observations are worth mentioning. 
6.1  IMPLICATIONS FOR PRACTICE AND POLICY 
The current landscape of family therapy approaches for treatment of youth drug use 
shows that many initiatives have been tried. A certain inconsistency seems to be 
developing: while existing FFT programs have yet to be evaluated thoroughly, new 
FFT interventions continue to surface. This is not only costly, it is also risky, as 
initiatives backed only by unclear research could ultimately be damaging. It is 
therefore crucial to know more about the effectiveness of treatments to understand 
where money should be spent and to understand exactly what kind of support young 
drug users can benefit from. Further all the available evidence was US-based, and so 
the findings may not be generalizable to other settings and systems outside the US. 
6.2  IMPLICATIONS FOR RESEARCH 
Firstly, it is important to address the need for more research in the field. A small 
body of evidence exists in relation to the treatment of young drug users, with only a 
very modest number of controlled evaluations of treatments for this group, all 
conducted in the US. Well-designed, randomized controlled trials from diverse 
locations within this population are needed and should be reported clearly in 
accordance with the principles of the CONSORT 2010 statement. 
Secondly, it is important to consider the possibility of adverse effects of these 
interventions. The popular belief is that FFT, as well as other family therapy 
approaches, is harmless, but very little research has been conducted that focuses on 
the potential harms of such family therapy approaches. 
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9 Tables 
9.1  CHARACTERISTICS OF INCLUDED STUDIES  
Waldron et al., 2001 
Methods Design: RCT (1 site, 4 intervention arms) total n = 120. We only use 3 
interventions arms with a total n=91 in this review 
Participants Age: 13-17 years (mean age 16). 
Gender:  80% male. 
Ethnicity: 47% Hispanic, 38% Anglo American, 7.50% Native American, 
7.50% Mixed/other. 
Family status: 45% was single parent household and 55% was two-parent 
household.  The average years of education for the primary caregivers were 
13.97 years. The average annual income of the caregivers was $38.537. 
Main drug of use: Marijuana. 
Severity: At pretreatment the average percentage of days of use for 
adolescent was approximately 60. 
Comorbidity: The percentages of the sample at or above the mean for 
various clinical problems were 29.7%, anxious/depressed; 27.3%, attention 
difficulties; 47.7%, externalizing behavior; and 45.3%, internalizing behavior. 
Inclusion criteria: Youths between the ages of 13 and 17 years were eligible 
for the study if they were living at home with a primary caretaker who was 
also willing to participate and if they met diagnostic criteria for a primary 
substance abuse disorder. 
Exclusion criteria: Youths primary abusing only alcohol and/or tobacco were 
excluded from the study. Youths and families were also excluded if the 
adolescent needed services other than outpatient treatment, if there was 
evidence of psychotic or organic state, or if a sibling was participating in the 
study. 
Interventions Intervention: Functional family therapy. The intervention consisted of 12 
weekly sessions of a system oriented, behaviorally based family therapy with 
2 phases: engaging families in treatment and enhancing motivation for 
change, and implementing behavioral changes in the family. 
Duration:  12 weekly sessions. The average number of weeks for completing 
the treatment was 16.29.  
Location:  The University of New Mexico Center for Family and Adolescent 
Research for drug-abuse treatment, USA. 
Comparison: Cognitive-behavioral therapy (CBT), combined individual and 
family therapy (not used in this review) and a group intervention. 
Outcomes Primary outcome: Days of use,  
Measure: Time Line Follow Back (TLFB) 
 
Secondary outcome: Delinquency 
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Measure: Youth Self Report (YSR)  
Notes The secondary outcome is reported in French et al. (2008) 
Friedman, 1989 
Methods Design: RCT (6 sites, 2 intervention arms) total n = 135 
Participants Age: 14-21 years (mean age 17.9). 
Gender:  61% male. 
Ethnicity: 90% white, 10% non-White. 
Family status: 8% of the parents were separated, 36% of the parents were 
divorced, and 50% of the parents were living together. 6% unknown.  
Main drug of use: Alcohol and Marijuana. 
Severity: The highest prevalence rates for use of substances during a 3-
month period before treatment were for alcohol; 88%, marijuana; 87%, 
amphetamines; 52%, cocaine; 28%, tranquilizers; 23%, hallucinogens; 22%, 
PCP; 15%, and barbiturates; 15%. 
Comorbidity: Not reported. 
Inclusion criteria: Not reported. 
Exclusion criteria: Not reported. 
Interventions Intervention: Functional family therapy. N= 85. 
Duration: 24 weekly sessions. 
Location:  In six different “drug-free” outpatient treatment programs. 
Comparison: Parent Group Method. N = 50. A program of 24 weekly 
sessions based on a package which combined ideas, elements, and 
procedures borrowed from: 1) the Parent Effectiveness Training (PET) 
method 2) the Parent Communication Project of the Canadian Addiction 
Research Foundation the parent Assertiveness Training program. 
The adolescent clients were not included in the family therapy. They were 
given individual drug counseling 
Outcomes Primary outcomes: No outcomes reported 
 
Secondary outcome: Education or vocational involvement    
Measures: Change that the Mothers Reported in the Clients’ Academic 
Problems. 
Notes  
 
9.2  CHARACTERISTICS OF EXCLUDED STUDIES  
Study Reason for exclusion 
Barton (1985) Participants are not in outpatient drug treatment primarily for non- opioid 
drug use. 
Doan (2012) Participants are not in outpatient drug treatment primarily for non- opioid 
drug use. 
Flicker (2008a) Focus is on comparison between ethnic matching of therapist and client. 
Flicker (2008b) Focus is on therapist alliance. 
Lally (2007) Participants are not in outpatient drug treatment primarily for non- opioid 
drug use. 
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Slesnick (2004) Participants are not in outpatient drug treatment primarily for non- opioid 
drug use. 
 
9.3  RISK OF BIAS JUDGEMENT, INDIVIDUAL STUDIES 
Waldron et al., 2001 
Bias Author’s judgement 
 
Support for judgement 
Sequence 
generation 
Low risk "An urn randomization procedure (…) was used to 
retain random allocation while balancing treatment 
condition groups on a priori continuous and 
categorical variables. With this procedure, relative 
probabilities of assignment to treatment groups (urns) 
are computer adjusted on the basis of previous 
randomizations to ensure pre-treatment group 
equivalence. The variables included in this project's 
urn were gender, age, level of substance use, 
ethnicity, psychiatric severity, and family constitution." 
(p. 804) 
Allocation 
concealment 
Unclear Not reported 
Blinding – 
outcome 
assessors? 
 The outcomes are given unclear as it is not possible 
to conclude whether the outcome assessors were 
blinded or not. 
Abstinence or 
reduction of drug 
use – biochemical 
test 
Unclear Not reported 
Abstinence or 
reduction of drug 
use – self reported 
estimates 
Unclear Not reported 
Abstinence or 
reduction of drug 
use – psychometric 
scales 
Not relevant Not relevant 
Abstinence or 
reduction of drug 
use – overall 
judgement 
Unclear * 
Social functioning 
and family 
functioning 
Not relevant Not relevant 
Education or 
vocational 
involvement 
Unclear Not reported 
Retention Not relevant Not relevant 
Risk behaviour Unclear Not reported 
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Other adverse 
effects 
Not relevant Not relevant 
Incomplete 
outcome data 
addressed? 
 "Some of the 120 adolescents failed to complete 
measures either at the 4-month (n=8) or at the 7-
month (n=7) assessment period. Six others missed 
both follow-up assessments; these 6 were removed 
from subsequent analysis, leaving 114 families. We 
assessed whether the values from remaining families 
appeared to be missing, randomly using the missing 
completely at random (MCAR) statistics (...). This 
statistic (...) provided evidence that the values were 
not missing at random. To avoid possible bias from 
subsequent analyses (i.e., listwise deletion) we 
created estimates, for the missing scores. The 
regression plus random residuals MVA module in 
SPSS provided the estimates....." (p. 807-808) 
 
Intent-to-treat sample used (p. 806). 
 
The outcome is given 1 as the study has very little 
missing data. 
Abstinence or 
reduction of drug 
use – biochemical 
test 
Unclear Not reported 
Abstinence or 
reduction of drug 
use – self reported 
estimates 
1 * 
Abstinence or 
reduction of drug 
use – psychometric 
scales 
Not relevant Not relevant 
Abstinence or 
reduction of drug 
use – overall 
judgement 
1 * 
Social functioning 
and family 
functioning 
Not relevant Not relevant 
Education or 
vocational 
involvement 
Not relevant Not relevant 
Retention Not relevant Not relevant 
Risk behaviour Unclear Not reported 
Other adverse 
effects 
Not relevant Not relevant 
Free of selective 
reporting? 
 The urinalysis outcome is given 3 as the 
measurement, and thereby data collection is made 
but the results are reported inappropriately.  
Outcomes for social functioning and family 
functioning is given 3 as these are mentioned in a 
footnote but not reported explicit in the study. 
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Other outcomes are given 1 as they are reported 
carefully. 
Abstinence or 
reduction of drug 
use – biochemical 
test 
3 "Analyses of the differences in urine screen rates 
over time or between condition differences did not 
approach statistical significance." (p. 809-810) 
(Note: the numerical outcomes (for the individual 
conditions) are however not reported) 
Abstinence or 
reduction of drug 
use – self reported 
estimates 
1 (see table 3 + French, table 2) 
Abstinence or 
reduction of drug 
use – psychometric 
scales 
Not relevant Not relevant 
Abstinence or 
reduction of drug 
use – overall 
judgement 
1 * 
Social functioning 
and family 
functioning 
3 "No statistically significant effects of treatment on 
either the Internalizing or the Externalizing Scale of 
the CBCL in the adolescent or primary caregiver 
family conflict scores were found." (p. 810) 
(Note: the numerical outcomes (for the individual 
conditions) are however not reported - se footnote 2, 
p. 810) 
Education or 
vocational 
involvement 
Not relevant Not relevant 
Retention Not relevant Not relevant 
Risk behaviour 1 (This measure is reported in French - see Table 2) 
Other adverse 
effects 
Not relevant Not relevant 
Free of other 
bias? 
1 To examine therapist effects, a repeated measures 
analysis was conducted with the percentage of days 
substance was used as the dependent measure and 
therapists as the independent variable with no 
significant interaction, F(2,28) = 0.96. 
 
To evaluate treatment adherence, we rated one 
therapy session for half of the total sample (n=60), 
selected random, on a 10 point scale for adherence 
(1= least adherence, 10 = greatest adherence) to the 
clinical manuals for the FFT condition (n=11, M=9.09, 
SD= 1.04), the CBT condition (N=11, M=08.91, 
SD=1.04), the family therapy sessions in the joint 
condition (n=9, M=9.33, SD=0.71), the CBT sessions 
in the joint condition (n=11, M09.09, SD=0.83), and 
the group condition (n=18, M09.50, SD=0.52). 
Ratings were based on standardized session 
checklists. The range of ratings was on a 7-10-point 
scale. A one-way analysis of variance (ANOVA) was 
calculated with the five tape sources operating as the 
independent variable and adherence rating treated as 
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the independent variable. The results indicated that 
the five sources of tapes were not significantly 
different in adherence rating, F(4,55) = 1.09, p< 0.37. 
 
This study is given 1 as it addresses treatment fidelity 
and reports that high adherence was achieved. 
A priori protocol? Unclear Not reported 
A priori analysis 
plan? 
Unclear "(…) however, 10 of these completed follow-up 
assessments, and their data were included in all 
analyses as part of the full intention-to-treat sample." 
(p. 806) 
* Denotes that support for judgement is described in the general risk of bias category 
field above.   
Friedman, 1989 
Bias Author’s judgement 
 
Support for judgement 
Sequence 
generation 
Unclear Not reported 
Allocation 
concealment 
Unclear Not reported 
Blinding – 
outcome 
assessors? 
Unclear The one outcome that is reported is given 
unclear as it is not possible to conclude whether 
the outcome assessors were blinded or not. 
Abstinence or 
reduction of drug 
use – biochemical 
test 
Not relevant No data reported 
Abstinence or 
reduction of drug 
use – self reported 
estimates 
Not relevant No data reported 
Abstinence or 
reduction of drug 
use – psychometric 
scales 
Not relevant No data reported 
Abstinence or 
reduction of drug 
use – overall 
judgement 
Not relevant No data reported 
Social functioning 
and family 
functioning 
Not relevant No data reported 
Education or 
vocational 
involvement 
Unclear Not reported 
Retention Not relevant No data reported 
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Risk behaviour Not relevant No data reported 
Other adverse 
effects 
Not relevant No data reported 
Incomplete 
outcome data 
addressed? 
3 "Of the 169 families who started in treatment, 
135, or 80%, were retrieved for follow-up 
evaluation 15 months later. (p. 338) In 93% of 
the families assigned to family therapy, either the 
mother alone or both parents started in 
treatment; but in only 67% of those assigned to a 
parent group did the mother alone or both 
parents start in treatment. (p. 337-338) 
Abstinence or 
reduction of drug 
use – biochemical 
test 
Unclear No data reported 
Abstinence or 
reduction of drug 
use – self reported 
estimates 
Unclear No data reported 
Abstinence or 
reduction of drug 
use – psychometric 
scales 
Unclear No data reported 
Abstinence or 
reduction of drug 
use – overall 
judgement 
Unclear No data reported 
Social functioning 
and family 
functioning 
Unclear No data reported 
Education or 
vocational 
involvement 
3 * 
Retention Unclear No data reported 
Risk behaviour Unclear No data reported 
Other adverse 
effects 
Unclear No data reported 
Free of selective 
reporting? 
4 No numeric outcome results except ‘Education 
or vocational involvement.’ 
Abstinence or 
reduction of drug 
use – biochemical 
test 
Not relevant Not relevant 
Abstinence or 
reduction of drug 
use – self reported 
estimates 
4 No numeric outcome results reported. 
Abstinence or 4 No numeric outcome results reported. 
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reduction of drug 
use – psychometric 
scales 
Abstinence or 
reduction of drug 
use – overall 
judgement 
4 No numeric outcome results reported. 
Social functioning 
and family 
functioning 
4 No numeric outcome results reported. 
Education or 
vocational 
involvement 
2 Only F value, p value and R2 change reported 
Retention 4 It is reportedd that "disprortionate number of 
parents of the relative older clients in the parent 
group subsample did not show for any of the 
parent sessions" (p. 339). However, it is also 
reported that "there were no significant 
differences between the two groups of clients on 
either the number of individual sessions or the 
number of peer group sessions in which they 
participated (p. 342). 
 
Risk behaviour 4 No numeric outcome results reported. 
Other adverse 
effects 
4 No numeric outcome results reported. 
Free of other 
bias? 
3 The degree to which the therapists adhered to 
the standardized treatment model as described 
in the training manual was measured as follows. 
Tapes of 20 family therapy sessions (of 12 
different families) were randomly selected, and a 
monitoring procedure was utilized in which 20-
minute segments of each of the sessions were 
scored by two independent raters for degree of 
adherence to the manual. In all, 346 therapist 
interventions were rated; only 10 of these, or 
3%, were considered to be inconsistent with the 
functional method as described in the manual. 
(p. 337) Measurements of adherence to the 
parent Group condition is not reported! 
 
A priori protocol? Unclear Not reported 
A priori analysis 
plan? 
Unclear Not reported  
* Denotes that support for judgement is described in the general risk of bias category 
field above.   
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9.4  OUTCOMES 
Study Outcome/follow-up Comparison Statistics 
 Drug use frequency 
Waldron et al. 
(2001) 
4-month follow up FFT vs. CBT SMD=0.78 (95% CI 0.25, 1.31)  
FFT vs Group SMD=0.97 (95% CI 0.44, 1.51)  
7-month follow FFT vs. CBT SMD=0.28 (95% CI -0.23, 0.79)  
FFT vs Group SMD=0.04 (95% CI -0.46, 0.55)  
Delinquency 
4-month follow up FFT vs. CBT SMD=0.55 (95% CI 0.04, 1.06)  
FFT vs Group SMD=0.37 (95% CI -0.14, 0.8)  
7-month follow FFT vs. CBT SMD=0.28 (95% CI -0.23, 0.79)  
FFT vs Group SMD=0.04 (95% CI -0.46, 0.55) 
Friedman (1989) Educational or vocational involvement 
15 month follow-up  FFT vs Parent 
group  
F-value=2.91, p-value=0.093 and change in R2=0.03  
 
9.5  ONGOING STUDIES AWAITING ASSESSMENT 
Title Family and Adolescent Motivational Incentives for 
Leveraging Youth 
Interventions FFT +/- contingency management vs Motivational Enhancement 
Therapy/CBT  +/- contingency management 
Design RCT 
Primary outcome measures Urine assays 
Secondary outcome measures Timeline Followback semi-structured interview  
Estimated enrollment 160 
Start date July 2012 
Estimated completion date April 2017 
Ages eligible 13 to 17 years 
Genders eligible Both 
Inclusion criteria 13 to 17 years of age 
Meets DSM-IV diagnostic criteria for substance abuse or 
dependence 
Living at home with the participating parent 
Sufficient residential stability to permit probable contact at follow- 
up(e.g., not homeless at time of intake) 
Exclusion criteria Evidence of psychotic or organic state of sufficient severity to 
interfere with the understanding of study instruments and 
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procedures 
Deemed dangerous to self or others at intake 
Services other than outpatient treatment are required for the 
youth (e.g., inpatient, detoxification) 
Marijuana use is reported as being less than 13% of the previous 
90 days 
Principal Investigator Michael Robbins, Oregon Research Institute 
 
 
Title 
Family Therapy Via Video Teleconference for Substance-
Abusing Rural Adolescents (RAFT) 
Interventions FFT as normal vs FFT via video link vs treatment as usual 
Design RCT 
Primary outcome measures Timeline Followback semi-structured interview 
Secondary outcome measures Urine assays 
Estimated enrollment 120 
Start date February 2012 
Estimated completion date November 2015 
Ages eligible 13 to 18 years 
Genders eligible Both 
Inclusion criteria  13-18 years of age 
 Meet DSM-IV diagnostic criteria for substance 
abuse or dependence 
 Reside with at least one parent or parental figure 
who is willing to participate in the study 
 Reside in a rural community approximately 30-50 
miles from the CFAR office 
 Have sufficient residential stability to permit contact 
with CFAR throughout the study (e.g., not homeless 
or runaway at time of intake)  
Exclusion criteria  Incarcerated or in a restrictive placement outside 
the home (e.g., residential treatment, in-patient 
care) 
 Evidence of a psychotic or organic state of sufficient 
severity to interfere with the ability to understand 
the research and clinical procedures 
 A sibling is already participating in the study 
 Evidence of posing a danger to self or others based 
on routine safety screening protocols (see Intake 
below) 
 Evidence that more intensive services other than 
outpatient treatment are required (e.g., in-patient 
care, detoxification) 
Principal Investigator Timothy J Ozechowski, Oregon Research Institute 
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10 Appendices 
10.1   CODE BOOK FOR DATA EXTRACTION 
Author Study x 
Year   
Country  
Is this study about an FBT intervention evaluation?  
Are the participants 11 - 21 years of age?   
Are the participants in outpatient drug treatment for 
illicit non-opioid drug use? 
 
Is the report a … 
P=Primary study  
RE=Review  (Effect/meta-analysis) 
RD=Review (Descriptive)  
D=Descriptive 
T=Theoretical paper 
O=Other 
 
Is the study a RCT with a control group?  
Is the study a non-randomized controlled study with a 
control group? 
 
 Is the study..  
Notes  
State reason if necessary for excluded or uncertain.   
If lack of info., state question(s) to be sent to study 
authors. 
 
Objectives of the study  
 How many separate sites/facilities are included in the 
study? 
 
If RCT, was random assignment performed in the 
same way in all sites? 
 
List all the treatment groups in the study  
Were there any implementation differences between 
groups? 
 
Location of treatment  
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Location details   
If multiple sites, were there any implementation 
differences between sites?  
 
Was participant inclusion criteria mentioned?  
If yes describe.  
Was participant exclusion criteria mentioned?  
If yes describe.  
Describe how the participants were referred to the 
intervention. 
 
Is the intervention mandated?   
If yes by whom and how many?   
Gender (e.g. % male)  
Age (details on age as presented in the study    
Race/ ethnicity   
Socioeconomic status  
Family composition  
Other characteristics   
Specify the main drug  
Provide short description of the distribution of drug 
use 
 
List/describe history/severity of drug use  
List any co-morbid condition  
Report total of participants randomized  
 
Intervention   
Name the intervention  
How is the intervention delivered?   
If Family, Other or Combination, describe the way it is 
delivered 
 
Describe any practical circumstances relevant to the 
intervention 
 
If deviation from manual, describe/list the components 
given in the intervention   
 
Describe any co-interventions given with the 
intervention 
 
Frequency of the intervention   
Intensity  
Duration of the intervention    
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Who delivered the intervention ?  
List program delivers qualifications.  
List program delivers characteristics.  
Describe methods used to ensure adherence to the 
intervention - specific to the the intervention 
 
What did the investigators do to check/measure 
treatment fidelity? 
 
Other important information  
 
Control group   
Name the control/comparison condition intervention?  
How is the control intervention delivered?   
If Family, Other or Combination, describe the way it is 
delivered. 
 
Describe any practical circumstances relevant to the 
intervention. 
 
If deviation from manual, describe/list the components 
given in the intervention   
 
Describe any co-interventions given with the 
comparison intervention 
 
Frequency of the intervention   
Intensity  
Duration of the intervention    
Who delivered the intervention?  
List program delivers qualifications.  
List program delivers characteristics.  
Describe methods used to ensure adherence to the 
intervention. 
 
What did the investigators do to check/measure 
treatment fidelity? 
 
Did they measure session attendance?  
Other important information  
 
Baseline time - describe how baseline is defined.  
End of treatment (from baseline time)  
...1st follow-up  
..2nd follow-up  
..3rd follow-up  
65        The Campbell Collaboration | www.campbellcollaboration.org 
 
..Other  
Author's main conclusion  
Limitations of the study as reported by the study 
authors 
 
Researchers affiliation with program  
Your own concerns and notes   
Question for review authors   
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10.2   RISK OF BIAS TOOL 
Risk of bias table 
Item Judgementa Description (quote from paper, 
or describe key information) 
1. Sequence generation   
2. Allocation concealment   
3. Confoundingb,         
4. Blinding?b                     
5. Incomplete outcome data 
addressed?b 
  
6. Free of selective reporting?b   
7. Free of other bias?   
8. A priori protocol?d   
9. A priori analysis plan?e   
aSome items on low/high risk/unclear scale (double-line border), some on 5 point 
scale/unclear (single line border), some on yes/no/unclear scale (dashed border). 
For all items, record “unclear” if inadequate reporting prevents a judgement being 
made. 
bFor each outcome in the study.  
cThis item is based on list of confounders considered important at the outset and 
defined in the protocol for the review (assessment against worksheet).  
dDid the researchers write a protocol defining the study population, intervention and 
comparator, primary and other outcomes, data collection methods, etc. in advance 
of starting the study? 
eDid the researchers have an analysis plan defining the primary and other outcomes, 
statistical methods, subgroup analyses, etc. in advance of starting the study? 
Risk of bias tool 
Studies for which RoB tool is intended 
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The risk of bias model is developed by Prof. Barnaby Reeves in association with the 
Cochrane Non-Randomised Studies Methods Group.14 This model, an extension of 
the Cochrane Collaboration’s risk of bias tool, covers both risk of bias in randomised 
controlled trials (RCTs and QRCTs), but also risk of bias in non-randomised studies 
(in this case non-randomised controlled trials NRCTs).   
The point of departure for the risk of bias model is the Cochrane Handbook for 
Systematic Reviews of interventions (Higgins & Green, 2008). The existing 
Cochrane risk of bias tool needs elaboration when assessing non-randomised studies 
because, for non-randomised studies, particular attention should be paid to 
selection bias / risk of confounding.   
Assessment of risk of bias 
Issues when using modified RoB tool to assess included non-randomised studies: 
 Use existing principle: score judgment and provide information 
(preferably direct quote) to support judgment 
 Additional item on confounding used for RCTs and NRCTs. 
 5-point scale for some items (distinguish “unclear” from intermediate 
risk of bias). 
 Keep in mind the general philosophy – assessment is not about whether 
researchers could have done better but about risk of bias; the assessment 
tool must be used in a standard way whatever the difficulty / 
circumstances of investigating the research question of interest and 
whatever the study design used. 
 Anchors: “1/No/low risk” of bias should correspond to a high quality 
RCT. “5/high risk” of bias should correspond to a risk of bias that means 
the findings should not be considered (too risky, too much bias, more 
likely to mislead than inform) 
1. Sequence generation 
 Low/high/unclear RoB item 
 Always high RoB (not random) for a non-randomised study 
 Might argue that this item redundant for NRS since always high – but 
important to include in RoB table (‘level playing field’ argument) 
2. Allocation concealment 
 Low/high/unclear RoB item 
                                                        
14 This risk of bias model was introduced by Prof. Reeves at a workshop on risk of bias in non-
randomised studies at SFI Campbell, February 2011. The model is a further development of work 
carried out in the Cochrane Non-Randomised Studies Method Group (NRSMG). 
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 Potentially low RoB for a non-randomised study, e.g. quasi-randomised 
(so high RoB to sequence generation) but concealed (reviewer judges that 
the people making decisions about including participants didn’t know 
how allocation was being done, e.g. odd/even date of birth/hospital 
number) 
3. RoB from confounding ( assess for each outcome) 
 Assumes a pre-specified list of potential confounders defined in the 
protocol 
 Low(1) / 2 / 3 / 4 / high(5) / unclear RoB item 
 Judgment needs to factor in: 
o proportion of confounders (from pre-specified list) that were 
considered 
o whether most important confounders (from pre-specified list) were 
considered 
o resolution/precision with which confounders were measured 
o extent of imbalance between groups at baseline 
o care with which adjustment was done (typically a judgment about the 
statistical modeling carried out by authors) 
 Low RoB requires that all important confounders are balanced at 
baseline (not primarily/not only a statistical judgment OR measured 
‘well’ and ‘carefully’ controlled for in the analysis. 
Assess against pre-specified worksheet. Reviewers will make a RoB judgment about 
each factor first and then ‘eyeball’ these for the judgment RoB table. 
4. RoB from lack of blinding (assess for each outcome, as per existing RoB tool) 
 Low(1) / 2 / 3 / 4 / high(5) / unclear RoB item 
 Judgment needs to factor in: 
o nature of outcome (subjective / objective; source of information) 
o who was / was not blinded and the risk that those who were not 
blinded could introduce performance or detection bias 
o see Ch.8 
5. RoB from incomplete outcome data (assess for each outcome, as per existing RoB 
tool) 
 Low(1) / 2 / 3 / 4 / high(5) / unclear RoB item 
 Judgment needs to factor in: 
o reasons for missing data 
o whether amount of missing data balanced across groups, with similar 
reasons 
o see Ch.8 
6. RoB from selective reporting (assess for each outcome, NB different to existing 
Ch.8 recommendation) 
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 Low(1) / 2 / 3 / 4 / high(5) /unclear RoB item 
 Judgment needs to factor in: 
o existing RoB guidance on selective outcome reporting 
o see Ch.8 
o also, extent to which analyses (and potentially other choices) could 
have been manipulated to bias the findings reported, e.g. choice of 
method of model fitting, potential confounders considered / included    
o look for evidence that there was a protocol in advance of doing any 
analysis / obtaining the data (difficult unless explicitly reported); 
NRS very different from RCTs. RCTs must have a protocol in advance 
of starting to recruit (for REC/IRB/other regulatory approval); NRS 
need not (especially older studies) 
o Hence, separate yes/no items asking reviewers whether they think 
the researchers had a pre-specified protocol and analysis plan. 
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10.3   CONFOUNDING WORKSHEET 
Assessment of how researchers dealt with confounding  
Method for identifying relevant confounders described by researchers:   yes                                                                                                                                                      
           no                                                                                                                            
If yes, describe the method used: 
 
Relevant confounders described:       yes 
           no 
List confounders described on next page 
 
Method used for controlling for confounding 
At design stage (e.g. matching, regression discontinuity, instrument variable):  
………………………………………………..      
………………………………………………..  
………………………………………………..            
 
At analysis stage (e.g. stratification, multivariate regression, difference-indifference):    
………………………………………………..      
………………………………………………..  
………………………………………………..            
 
 
Describe confounders controlled for below 
 
 
Confounders described by researchers 
Tick (yes[0]/no[1] judgment) if confounder considered by the researchers [Cons’d?] 
Score (1[good precision] to 5[poor precision]) precision with which confounder measured 
Score (1[balanced] to 5[major imbalance]) imbalance between groups 
Score (1[very careful] to 5[not at all careful]) care with which adjustment for confounder was carried 
out 
Confounder Considered Precision Imbalance Adjustment 
Gender     
Age     
History of drug use      
Other      
Other:     
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Other:     
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10.4   SEARCH HISTORIES EXAMPLES 
Bibliotek.dk update  June 2013 
Search 
number 
Terms Totals 
S1  
 
(Func?  og  og  Famil?" og therap*) eller FFT 13 
 
Cinahl May 2011 
Ebsco platform 
Search 
number 
Terms Totals 
S1  
 
TX FFT or TX Function* n1 Famil* n1 therap* 87 
 
Criminal Justice Abstracts May 17 2011 
Ebsco platform 
Search 
number 
Terms Totals 
S1  
 
TX FFT or TX Function* n1 Famil* n1 therap* 30 
 
Cochrane library update June 2013 
Search 
number 
Terms Totals 
S1  
 
FFT or Function* near/1 Famil* near/1 Therap* 62 
 
Embase update June 2013 
Ovid platform 
Search 
number 
Terms 
 
Totals 
S1  
S2 
S3 
S4 
fft.ti,ab,kw 
(function* adj1 Famil* adj1 therap*).ti,ab,kw 
1 or 2  
limit 3 to yr="2011 - 2013" 
2050 
32 
2074 
269 
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ERIC May 2011 
Ebsco 
Search 
number 
Terms Totals 
S1  
 
TX FFT or TX Function* n1 Famil* n1 therap* 905 
 
Libris June 2011 
Search 
number 
Terms Totals 
S1  
 
FFT OR Function* Famil* Therap*  103 
 
Medline update June 2013 
Search 
number 
Terms Totals 
S1  
S2 
S3 
S4 
(function* adj1 Famil* adj1 therap*).ab,kw,sh,ti. 
fft.ab,kw,sh,ti. 
2 or 3 
limit 4 to yr="2011 - 2013" 
23 
1491 
1509 
144 
 
PsycINFO Update July 2013 
Ebsco platform 
Search 
number 
Terms Totals 
S1  
S2 
 
TX FFT or TX Function* n1 Famil* n1 therap* 
Limiters - Publication Year from: 2011-2013 
Search modes - Boolean/Phrase 
459 
72 
 
Social Care Online June 2011 
Search 
number 
Terms Totals 
S1  
 
(freetext="fft" or freetext="function* famil* therap*")  1782 
 
 
74        The Campbell Collaboration | www.campbellcollaboration.org 
 
SocINDEX  
Ebsco platform 
Search 
number 
Terms Totals 
S1  
 
TX FFT or TX Function* n1 Famil* n1 therap* 394 
 
Libris May 2011 
Search 
number 
Terms Totals 
S1  
 
Resultat av søket: FFT eller Function? og Famil? og Therap? 
 
85 
 
Science Citation Index June 2011 
Search 
number 
Terms Totals 
S1  
 
 (Functional same Famil* same Therap*)  
 
85 
 
Social Science Citation Index June 2011 
Search 
number 
Terms Totals 
S1  
 
 Topic=(fft) OR Topic=((Functional same Famil* same Therap*))  
Databases 
223 
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11 Figures 
11.1   FLOW CHART FOR LITERATURE SEARCH 
 
 
 
Database literature 
SocIndex 471 
Eric 31 
SSCI 733 
SCI 85 
Crimiminal Justice 
Abstracts 
38 
Cinahl 87 
Social Care Online 1785 
PsycInfo 331 
Cochrane 62 
Medline 1030 
Embase 1174 
Bibliotek.dk 13 
Libris 127 
Bibsys 24 
Total 5,991 
  
 
Grey literature 
  
Google/Google scholar   
450 
Dissexpress 200 
Multi-disciplinary sites 17 
Subject specific sites 58 
  
Total 725 
 
Hand search 
Addiction 527 
Journal of Substance 
Abuse Treatment 
214 
Journal of Clinical Child 
and Adolescent 
Psychology 
89 
Journal of Consulting & 
Clinical Psychology 
126 
Research on Social 
Work Practice 
128 
Snowball 567 
Expert list 0 
  
Total 1,651 
 
1648 records excluded for 
being duplicates. 
6719 potential relevant records (database: 4343, 
grey: 725 and 1,651 from hand search etc.) 
screened for retrieval. 
6611 records excluded 
for not fulfilling 
first level screening 
questions 
108 records (90 databases, and 18 snowball) 
retrieved for full text screening. 
2 studies (3 papers) finally met the eligibility criteria 
and where included in the review. 
3 records met the inclusion criteria and were 
assessed for data extraction. 
97 records, (were 
excluded for not 
fulfilling the second 
level screening criteria) 
6 potentially relevant 
records were 
subsequently excluded.  
2 were unobtainable. 
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